Application of Free Energy Perturbation for the Design of BACE1 Inhibitors

被引:88
|
作者
Ciordia, Myriam [1 ,2 ]
Perez-Benito, Laura [1 ,3 ]
Delgado, Francisca [1 ]
Trabanco, Andres A. [1 ]
Tresadern, Gary [1 ]
机构
[1] Janssen Res & Dev, C Jarama 75A, Toledo 45007, Spain
[2] Univ CEU San Pablo, Fac Farm, Dept Quim & Bioquim, Urbanizac Monteprincipe Ctra, Madrid 28668, Spain
[3] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Bellaterra 08193, Spain
关键词
BETA-SECRETASE INHIBITORS; ALZHEIMERS-DISEASE; CLEAVING ENZYME; REPLICA EXCHANGE; BINDING; HIT; GENERATION; PREDICTION; DYNAMICS; PROTEIN;
D O I
10.1021/acs.jcim.6b00220
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Novel spiroaminodihydropyrroles probing for optimized interactions at the P3 pocket of beta-secretase 1 (BACE1) were designed with the use of free energy perturbation (FEP) calculations. The resulting molecules showed pIC(50) potencies in enzymatic BACE1 inhibition assays ranging from approximately 5 to 7. Good correlation was observed between the predicted activity from the FEP calculations and experimental activity. Simulations run with a default 5 ns approach delivered a mean unsigned error (MUE) between prediction and experiment of 0.58 and 0.91 kcal/mol for retrospective and prospective applications, respectively. With longer simulations of 10 and 20 ns, the MUE was in both cases 0.57 kcal/mol for the retrospective application, and 0.69 and 0.59 kcal/mol for the prospective application. Other considerations that impact the quality of the Calculations are discussed. This work provides an example of the value of FEP as a computational tool for drug discovery.
引用
收藏
页码:1856 / 1871
页数:16
相关论文
共 50 条
  • [1] In silico design of β-secretase 1 (BACE1) inhibitors
    Fraczkiewicz, Robert
    Miller, David
    Lawless, Michael
    Clark, Robert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [2] Design and synthesis of cyclic acylguanidines as BACE1 inhibitors
    Jia-Kuo Liu
    Wei Gu
    Xiao-Rui Cheng
    Jun-Ping Cheng
    Wen-Xia Zhou
    Ai-Hua Nie
    Chinese Chemical Letters, 2015, 26 (10) : 1327 - 1330
  • [3] Design and synthesis of cyclic acylguanidines as BACE1 inhibitors
    Liu, Jia-Kuo
    Gu, Wei
    Cheng, Xiao-Rui
    Cheng, Jun-Ping
    Zhou, Wen-Xia
    Nie, Ai-Hua
    CHINESE CHEMICAL LETTERS, 2015, 26 (10) : 1327 - 1330
  • [4] Novel thio-derivative of phenylnorstatine and its application to the BACE1 inhibitors design
    Ziora, Z.
    Kasai, S.
    Hidaka, K.
    Nagamine, A.
    Kimura, T.
    Hayashi, Y.
    Kiso, Y.
    JOURNAL OF PEPTIDE SCIENCE, 2006, 12 : 169 - 169
  • [5] Design and discovery of macrocyclic diaminopropanes as potent inhibitors of BACE1
    Marcin, Lawrence R.
    Thompson, Lorin A.
    Higgins, Mendi A.
    Shi, JianLiang
    Boy, Kenneth M.
    Olson, Richard E.
    Good, Andrew C.
    Burton, Catherine R.
    Barten, Donna M.
    Muckelbauer, Jodi K.
    Calambur, Deepa
    Camac, Daniel M.
    Chang, ChiehYing
    Toyn, Jeremy H.
    Lentz, Kimberley A.
    Grace, James E.
    Herbst, Grace John J.
    Marino, Anthony M.
    Meredith, Jere E.
    Albright, Charlie F.
    Macor, John E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [6] Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors
    Xu, Ying-zi
    Yuan, Shendong
    Bowers, Simeon
    Hom, Roy K.
    Chan, Wayman
    Sham, Hing L.
    Zhu, Yong L.
    Beroza, Paul
    Pan, Hu
    Brecht, Eric
    Yao, Nanhua
    Lougheed, Julie
    Yan, Jiangli
    Tam, Danny
    Ren, Zhao
    Ruslim, Lany
    Bova, Michael P.
    Artis, Dean R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (10) : 3075 - 3080
  • [7] Structure-based design of acylguanidine BACE1 inhibitors
    Manas, ES
    Chopra, R
    Cole, DC
    Stock, JR
    Jennings, LD
    Lovering, FE
    Condon, JS
    Zhou, P
    Solvibile, WR
    Aulabaugh, A
    Lo, MC
    Cowling, R
    Jin, G
    Turner, MJ
    Hu, Y
    Wagner, E
    Fan, KY
    Alvarez, JC
    Malamas, MS
    Bard, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U1293 - U1294
  • [8] Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor
    Cumming, Jared N.
    Smith, Elizabeth M.
    Wang, Lingyan
    Misiaszek, Jeffrey
    Durkin, James
    Pan, Jianping
    Iserloh, Ulrich
    Wu, Yusheng
    Zhu, Zhaoning
    Strickland, Corey
    Voigt, Johannes
    Chen, Xia
    Kennedy, Matthew E.
    Kuvelkar, Reshma
    Hyde, Lynn A.
    Cox, Kathleen
    Favreau, Leonard
    Czarniecki, Michael F.
    Greenlee, William J.
    McKittrick, Brian A.
    Parker, Eric M.
    Stamford, Andrew W.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (07) : 2444 - 2449
  • [9] Modeling Potenial BACE1 Inhibitors
    Guevara, Johnny
    Mai Zahran
    Department, Alberto
    FASEB JOURNAL, 2018, 32 (01):
  • [10] New aminohydantoins as BACE1 inhibitors
    Malamas, Michael S.
    Robichaud, Albert
    Erdei, Jim
    Quagliato, Dominick
    Fobare, William
    Porte, Alex
    Kim, Jean
    Solvibile, William
    Zhou, Ping
    McDevitt, Robert
    Morris, Koi
    Antane, Schuyler
    Turner, Jim
    Wagner, Erik
    Fan, Kristi
    Bard, Jonathan
    Jacobsen, Steve
    Reinhart, Peter
    Pangalos, Menelas
    Riddell, David
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240